---
schema_version: "secwatch.filing_event.v1"
accession: "0001013762-24-001812"
form_type: "8-K"
ticker: "PHGE"
cik: "0001739174"
company_name: "BiomX Inc."
filed_at: "2024-07-29T23:59:59+00:00"
generated_at: "2026-05-31T15:44:52.541739+00:00"
event_type: "regulatory"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# BiomX gets NYSE American approval of compliance plan; deadline extended to Nov 2025

## Summary
- NYSE American accepted BiomX's plan to regain compliance with continued listing standards under Sections 1003(a)(i), (ii), (iii).
- Company has until November 23, 2025 to meet listing requirements; stock continues trading on NYSE American under PHGE.
- Previously disclosed deficiency in May 2024; plan acceptance avoids immediate delisting but periodic reviews apply.
- If compliance not achieved by Nov 2025 or insufficient progress, NYSE American may initiate delisting.

## SEC filing metadata
- accession: 0001013762-24-001812
- form_type: 8-K
- ticker: PHGE
- cik: 0001739174
- company_name: BiomX Inc.
- filed_at: 2024-07-29T23:59:59+00:00
- event_type: regulatory
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1739174/000101376224001812/0001013762-24-001812-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1739174/000101376224001812/ea0210175-8k_biomx.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001013762-24-001812
- JSON: https://secwatch.observer/filing/0001013762-24-001812.json
- Plain text: https://secwatch.observer/filing/0001013762-24-001812.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.